Alvey et al. (82) showed that ex vivo manipulated, SIRPα-inhibited macrophages when systemically injected to mice were able to accumulate into the tumor sites (human lung cancer model), leading to tumor cells engorgement and cancer regression. The gene discussed is SIRPA; the disease is neoplasm.